Skip to content
Life Sciences Series A Founded 2015

BOYDSense

Developer of a breath-based diabetes monitor. The Lassie breath analyzer is a non-invasive device for measuring critical biomarkers from exhaled breath and detects glucose levels. This device also detects and monitors other diseases such as cancer, obesity, asthma, and more. Operating in the Life Sciences > Diabetes, High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology…

📍 Toulouse, France · Diabetes,

Funding snapshot

Last roundSeries A
Amount$8M
Date17 April 2024
Total raised$8M
Team size16

About

Developer of a breath-based diabetes monitor. The Lassie breath analyzer is a non-invasive device for measuring critical biomarkers from exhaled breath and detects glucose levels. This device also detects and monitors other diseases such as cancer, obesity, asthma, and more. Operating in the Life Sciences > Diabetes, High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology sector. with business models spanning Wearable Technology > Health and Wellness Devices > Diabetes Monitoring, Disease Self Management > Diabetes > Monitoring > Glucose > Device. Founded in 2015, headquartered in Toulouse, France. The company has raised $7.5M at the Series A stage, backed by investors including EIC Fund, Diabetes Venture Fund, BioSerenity, Europa, Jolt Capital.

Business model

Wearable Technology > Health and Wellness Devices > Diabetes Monitoring,

Disease Self Management > Diabetes > Monitoring > Glucose > Device,

Diabetes > Medical Devices > Monitoring Devices > CGM > Non-Invasive

Institutional investors

EIC Fund Diabetes Venture Fund BioSerenity Europa Jolt Capital Ambrosia Investments

Latest coverage

No articles yet.

Raising like BOYDSense?

Analyze your pitch deck before your next raise.

Analyze My Deck →